Inventor · disambiguated record
Robertus Cornelis Roovers
Also filed as: ROOVERS ROBERTUS CORNELIS
5 granted patents·10 pending applications·11 citations·filing 2015–2025
72Inventor score
Top patents by PatentIndex Score
15 records- 0192US10844127B2Antibodies that bind EGFR and ErbB3MERUS NV·Filed 2015·Granted Nov 24, 2020·8 cites·18 claims
- 0291US11820825B2Methods of treating a subject having an EGFR-positive and/or ErbB-3-positive tumorMERUS NV·Filed 2020·Granted Nov 21, 2023·2 cites·12 claims
- 0382US12325746B2Bispecific antibodyONO PHARMACEUTICAL CO·Filed 2020·Granted Jun 10, 2025·1 cites·6 claims
- 0478US2024052043A1Antibodies that bind egfr and erbb3MERUS NV·Filed 2023·Application pending·0 cites
- 0573US12428493B2Antibodies that bind PSMA and gamma-delta T cell receptorsLAVA THERAPEUTICS N V·Filed 2024·Granted Sep 30, 2025·0 cites·8 claims
- 0673US2024174756A1Antibodies that bind egfr and cmetMERUS NV·Filed 2023·Application pending·0 cites
- 0765US2025368736A1Bispecific antibodyONO PHARMACEUTICAL CO·Filed 2025·Application pending·0 cites
- 0860US2025109204A1Compositions comprising antibodies that bind gamma-delta t cell receptorsLAVA THERAPEUTICS N V·Filed 2024·Application pending·0 cites
- 0960US2025230240A1Variant antibodies that bind gamma-delta t cell receptorsLAVA THERAPEUTICS N V·Filed 2024·Application pending·0 cites
- 1058US2024409634A1CD33 x Vd2 MULTISPECIFIC ANTIBODIES FOR THE TREATMENT OF CANCERJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 1157US11773170B2Antibodies that bind EGFR and cMETMERUS NV·Filed 2018·Granted Oct 3, 2023·0 cites·16 claims
- 1255US2023303694A1Antibodies that bind gamma-delta t cell receptorsLAVA THERAPEUTICS N V·Filed 2023·Application pending·0 cites
- 1353US2024141071A1Antibodies that bind cd123 and gamma-delta t cell receptorsLAVA THERAPEUTICS N V·Filed 2022·Application pending·0 cites
- 1453US2023272110A1Antibodies that bind psma and gamma-delta t cell receptorsLAVA THERAPEUTICS N V·Filed 2021·Application pending·0 cites
- 1550US2023036284A1TREATMENT OF CANCER COMPRISING ADMINISTRATION OF Vg9Vd2 T CELL RECEPTOR BINDING ANTIBODIESLAVA THERAPEUTICS N V·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robertus Cornelis Roovers files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →